Dendritic cells, but not macrophages, efficiently phagocytose apoptotic cells and cross-present viral, tumor, and self-antigens to CD8+ T cells. This in vitro pathway corresponds to the in vivo phenomena of cross-priming and cross-tolerance. Here, we demonstrate that phagocytosis of apoptotic cells is restricted to the immature stage of dendritic cell (DC) development, and that this process is accompanied by the expression of a unique profile of receptors, in particular the αvβ5 integrin and CD36. Upon maturation, these receptors and, in turn, the phagocytic capacity of DCs, are downmodulated. Macrophages engulf apoptotic cells more efficiently than DCs, and although they express many receptors that mediate this uptake, they lack the αvβ5 integrin. Furthermore, in contrast to DCs, macrophages fail to cross-present antigenic material contained within the engulfed apoptotic cells. Thus, DCs use unique pathways for the phagocytosis, processing, and presentation of antigen derived from apoptotic cells on class I major histocompatibility complex. We suggest that the αvβ5 integrin plays a critical role in the trafficking of exogenous antigen by immature DCs in this cross-priming pathway.
Skip Nav Destination
Article navigation
5 October 1998
Article|
October 05 1998
Immature Dendritic Cells Phagocytose Apoptotic Cells via αvβ5 and CD36, and Cross-present Antigens to Cytotoxic T Lymphocytes
Matthew L. Albert,
Matthew L. Albert
From the *Laboratory of Cellular Physiology and Immunology, The Rockefeller University, New York 10021; and the ‡Division of Hematology-Oncology, Cornell University Medical College, New York 10021
Search for other works by this author on:
S.Frieda A. Pearce,
S.Frieda A. Pearce
From the *Laboratory of Cellular Physiology and Immunology, The Rockefeller University, New York 10021; and the ‡Division of Hematology-Oncology, Cornell University Medical College, New York 10021
Search for other works by this author on:
Loise M. Francisco,
Loise M. Francisco
From the *Laboratory of Cellular Physiology and Immunology, The Rockefeller University, New York 10021; and the ‡Division of Hematology-Oncology, Cornell University Medical College, New York 10021
Search for other works by this author on:
Birthe Sauter,
Birthe Sauter
From the *Laboratory of Cellular Physiology and Immunology, The Rockefeller University, New York 10021; and the ‡Division of Hematology-Oncology, Cornell University Medical College, New York 10021
Search for other works by this author on:
Pampa Roy,
Pampa Roy
From the *Laboratory of Cellular Physiology and Immunology, The Rockefeller University, New York 10021; and the ‡Division of Hematology-Oncology, Cornell University Medical College, New York 10021
Search for other works by this author on:
Roy L. Silverstein,
Roy L. Silverstein
From the *Laboratory of Cellular Physiology and Immunology, The Rockefeller University, New York 10021; and the ‡Division of Hematology-Oncology, Cornell University Medical College, New York 10021
Search for other works by this author on:
Nina Bhardwaj
Nina Bhardwaj
From the *Laboratory of Cellular Physiology and Immunology, The Rockefeller University, New York 10021; and the ‡Division of Hematology-Oncology, Cornell University Medical College, New York 10021
Search for other works by this author on:
Matthew L. Albert
From the *Laboratory of Cellular Physiology and Immunology, The Rockefeller University, New York 10021; and the ‡Division of Hematology-Oncology, Cornell University Medical College, New York 10021
S.Frieda A. Pearce
From the *Laboratory of Cellular Physiology and Immunology, The Rockefeller University, New York 10021; and the ‡Division of Hematology-Oncology, Cornell University Medical College, New York 10021
Loise M. Francisco
From the *Laboratory of Cellular Physiology and Immunology, The Rockefeller University, New York 10021; and the ‡Division of Hematology-Oncology, Cornell University Medical College, New York 10021
Birthe Sauter
From the *Laboratory of Cellular Physiology and Immunology, The Rockefeller University, New York 10021; and the ‡Division of Hematology-Oncology, Cornell University Medical College, New York 10021
Pampa Roy
From the *Laboratory of Cellular Physiology and Immunology, The Rockefeller University, New York 10021; and the ‡Division of Hematology-Oncology, Cornell University Medical College, New York 10021
Roy L. Silverstein
From the *Laboratory of Cellular Physiology and Immunology, The Rockefeller University, New York 10021; and the ‡Division of Hematology-Oncology, Cornell University Medical College, New York 10021
Nina Bhardwaj
From the *Laboratory of Cellular Physiology and Immunology, The Rockefeller University, New York 10021; and the ‡Division of Hematology-Oncology, Cornell University Medical College, New York 10021
Address correspondence to Nina Bhardwaj, Laboratory of Cellular Physiology and Immunology, The Rockefeller University, 1230 York Ave., New York, NY 10021. Phone: 212-327-7597; Fax: 212-327-8875; E-mail: [email protected]
Received:
June 23 1998
Revision Received:
August 11 1998
Online ISSN: 1540-9538
Print ISSN: 0022-1007
1998
J Exp Med (1998) 188 (7): 1359–1368.
Article history
Received:
June 23 1998
Revision Received:
August 11 1998
Citation
Matthew L. Albert, S.Frieda A. Pearce, Loise M. Francisco, Birthe Sauter, Pampa Roy, Roy L. Silverstein, Nina Bhardwaj; Immature Dendritic Cells Phagocytose Apoptotic Cells via αvβ5 and CD36, and Cross-present Antigens to Cytotoxic T Lymphocytes . J Exp Med 5 October 1998; 188 (7): 1359–1368. doi: https://doi.org/10.1084/jem.188.7.1359
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement